Award

Endothelial cell estrogen receptor alpha protects from atherosclerosis inflammation in females

Description: Understanding sex-specific mechanisms driving cardiovascular disease (CVD) is necessary to develop precision strategies to prevent CVD. Myocardial infarction is most often caused by the rupture of inflamed atherosclerotic (athero) plaques. Athero develops from endothelial cell (EC) damage that induces expression of adhesion molecules (AMs) resulting in leukocyte recruitment. Women are protected from CVD relative to men, and female athero-prone mice have reduced athero inflammation compared to males, suggesting that females may be protected from CVD events by decreased plaque inflammation. Since CVD risk increases in women with age, estrogen (E) and E receptors (ERs) have been implicated. Indeed, E treatment in postmenopausal women has been shown to reduce CVD events when began <10 years post-menopause. Prior studies show that ERs downregulate known drivers of EC inflammation: (1) ERa inhibits mineralocorticoid receptor (MR) transcriptional activity in vitro and (2) ER can inhibit the transcription factor nuclear factor kappa B (NFkB), a known inducer of AM expression. Whether these mechanisms contribute to protection from athero inflammation in females remains unknown. We propose to test the hypothesis that EC-ERa protects against athero inflammation in females by downregulating AM expression via distinct MR and NFkB-mediated mechanisms. In Aim 1, we test the hypothesis in vitro that EC-ERa inhibits AM expression by preventing EC-MR and NFkB binding to AM promoters, attenuating leukocyte adhesion to ECs. To test this, in human aortic ECs from women we will treat with ERa siRNA knock-down +/- estradiol to measure (1) ERa, MR, and NFkB enrichment on AM promoters by chromatin immunoprecipitation (ChIP)-PCR, (2) AM expression, and (3) adhesion of fluorescent leukocytes to ECs. In Aim 2, we test the hypothesis in vivo that EC-ERa inhibits AM expression and protects from athero inflammation in females using novel cell-specific knock-out mouse models in which ERa, MR, or both ERa and MR are deleted in ECs and crossed to the LDLR background. In female mice, we will measure (1) leukocyte trafficking by intravital microscopy, (2) plaque composition by histology, (3) AM expression, and (4) ERa and NFkB enrichment on AM promoters in aortic tissue after 12 weeks of high fat diet. Successful completion of these aims will reveal EC-ERa-mediated pathways that regulate AMs and leukocyte trafficking, clarifying mechanisms by which young females are protected from CVD.
Amount: $69,550
Funding type: training
Funder scheme: Predoctoral Fellowship
Start date: 2025-01-01
End date: 2025-09-16
Investigator: Nicole Svedberg (lead)
Subfield: Endocrinology
Funded outputs count: 1
Funder award ID: 25PRE1374117
OpenAlex ID: G6074495490